PubMed

Dosage dependency of intravitreal triamcinolone acetonide as treatment for diabetic macular oedema.

Spandau UH, Derse M, Schmitz-Valckenberg P, Papoulis C, Jonas JB.

Br J Ophthalmol. 2005 Aug;89(8):999-1003.PMID: 16024853 [PubMed - indexed for MEDLINE]Related articlesFree article

Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema.

Jonas JB, Spandau UH, Kamppeter BA, Vossmerbaeumer U, Harder B, Sauder G.

Ophthalmology. 2006 May;113(5):800-4. Epub 2006 Mar 13.PMID: 16530840 [PubMed - indexed for MEDLINE]Related articles

Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.

Cardillo JA, Melo LA Jr, Costa RA, Skaf M, Belfort R Jr, Souza-Filho AA, Farah ME, Kuppermann BD.

Ophthalmology. 2005 Sep;112(9):1557-63.PMID: 16019075 [PubMed - indexed for MEDLINE]Related articles

Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema.

Jonas JB, Degenring RF, Kamppeter BA, Kreissig I, Akkoyun I.

Am J Ophthalmol. 2004 Jul;138(1):158-60.PMID: 15234306 [PubMed - indexed for MEDLINE]Related articles

Inter-eye difference in diabetic macular edema after unilateral intravitreal injection of triamcinolone acetonide.

Jonas JB, Harder B, Kamppeter BA.

Am J Ophthalmol. 2004 Dec;138(6):970-7.PMID: 15629288 [PubMed - indexed for MEDLINE]Related articles

Two-year results of intravitreal triamcinolone acetonide injection for the treatment of diabetic macular edema.

Batioğlu F, Ozmert E, Parmak N, Celik S.

Int Ophthalmol. 2007 Oct;27(5):299-306. Epub 2007 Apr 24.PMID: 17453151 [PubMed - indexed for MEDLINE]Related articles

Intravitreal triamcinolone acetonide as primary treatment for diffuse diabetic macular edema: a prospective noncomparative interventional case series.

Nicolò M, Nasciuti F, Lai S, Ghiglione D, Borgia L, Calabria G.

Eur J Ophthalmol. 2006 Jan-Feb;16(1):129-33.PMID: 16496256 [PubMed - indexed for MEDLINE]Related articles

Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study).

Paccola L, Costa RA, Folgosa MS, Barbosa JC, Scott IU, Jorge R.

Br J Ophthalmol. 2008 Jan;92(1):76-80. Epub 2007 Oct 26.PMID: 17965109 [PubMed - indexed for MEDLINE]Related articles

Intravitreal triamcinolone acetonide for diabetic macular edema.

Chieh JJ, Roth DB, Liu M, Belmont J, Nelson M, Regillo C, Martidis A.

Retina. 2005 Oct-Nov;25(7):828-34.PMID: 16205559 [PubMed - indexed for MEDLINE]Related articles

Intravitreal injection of triamcinolone for diffuse diabetic macular edema.

Jonas JB, Kreissig I, Söfker A, Degenring RF.

Arch Ophthalmol. 2003 Jan;121(1):57-61.PMID: 12523885 [PubMed - indexed for MEDLINE]Related articles

Dose dependent effects of intravitreal triamcinolone acetonide on diffuse diabetic macular edema.

Bae JS, Park SJ, Ham IR, Lee TG.

Korean J Ophthalmol. 2009 Jun;23(2):80-5. Epub 2009 Jun 9.PMID: 19568355 [PubMed - indexed for MEDLINE]Related articlesFree article

Predictive factors for visual acuity after intravitreal triamcinolone treatment for diabetic macular edema.

Jonas JB, Martus P, Degenring RF, Kreissig I, Akkoyun I.

Arch Ophthalmol. 2005 Oct;123(10):1338-43.PMID: 16219724 [PubMed - indexed for MEDLINE]Related articles

A prospective randomised trial of different doses of intravitreal triamcinolone for diabetic macular oedema.

Lam DS, Chan CK, Mohamed S, Lai TY, Li KK, Li PS, Tsang CW, Chan WM, Shanmugam MP.

Br J Ophthalmol. 2007 Feb;91(2):199-203. Epub 2006 Sep 14.PMID: 16973659 [PubMed - indexed for MEDLINE]Related articles

Cataract surgery combined with intravitreal injection of triamcinolone acetonide.

Jonas JB, Kreissig I, Budde WM, Degenring RF.

Eur J Ophthalmol. 2005 May-Jun;15(3):329-35.PMID: 15945000 [PubMed - indexed for MEDLINE]Related articles

Follow-up after intravitreal triamcinolone acetonide for diabetic macular edema.

Jonas JB, Spandau UH, Kamppeter BA, Vossmerbaeumer U, Harder B.

Eur J Ophthalmol. 2006 Jul-Aug;16(4):566-72.PMID: 16952096 [PubMed - indexed for MEDLINE]Related articles

Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial.

Massin P, Audren F, Haouchine B, Erginay A, Bergmann JF, Benosman R, Caulin C, Gaudric A.

Ophthalmology. 2004 Feb;111(2):218-24; discussion 224-5.PMID: 15019365 [PubMed - indexed for MEDLINE]Related articles

Intravitreal triamcinolone improves vision in eyes with chronic diabetic macular oedema refractory to laser photocoagulation.

Negi AK, Vernon SA, Lim CS, Owen-Armstrong K.

Eye (Lond). 2005 Jul;19(7):747-51.PMID: 15359268 [PubMed - indexed for MEDLINE]Related articles

[Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases]

Jonas JB, Kreissig I, Kamppeter B, Degenring RF.

Ophthalmologe. 2004 Feb;101(2):113-20. Review. German. PMID: 14991306 [PubMed - indexed for MEDLINE]Related articles

Intravitreal triamcinolone for refractory diabetic macular edema.

Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E, Baumal C.

Ophthalmology. 2002 May;109(5):920-7.PMID: 11986098 [PubMed - indexed for MEDLINE]Related articles

Prospective evaluation of intravitreal triamcinolone acetonide injection in macular edema associated with retinal vascular disorders.

Tewari HK, Sony P, Chawla R, Garg SP, Venkatesh P.

Eur J Ophthalmol. 2005 Sep-Oct;15(5):619-26.PMID: 16167293 [PubMed - indexed for MEDLINE]Related articles